354PAnti-HER-2 therapies and left ventricular dysfunction the renaissance study

ConclusionsWhile the LVD related with AH2 therapies is a real problem in HER2+ breast cancer patients ’ care, a timely diagnosis and t. with therapies for HF can allow LVEF recovery and specific oncological therapy continuance.Legal entity responsible for the studyThe authors.FundingHas not received any funding.DisclosureAll authors have declared no conflicts of interest.
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research